Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: March 2015
This report presents 2012 to 2013 findings from a federally funded program that supports community-based mental health services for children experiencing serious emotional disturbances. It describes the system of care approach, service characteristics and use, and child outcomes.
The Comprehensive Community Mental Health Services for Children and Their Families Program, Evaluation Findings
Published: November 2013
This report presents program evaluation findings of a federally funded initiative that supports systems of care for community-based mental health services for children, youth, and their families. It includes data from fiscal year 2011 data that track service characteristics, use, and outcomes.